{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T15:51:09Z","timestamp":1740153069897,"version":"3.37.3"},"reference-count":12,"publisher":"The Journal of Rheumatology","issue":"Suppl 2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"accepted":{"date-parts":[[2024,5,1]]},"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:p>During the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2023 annual meeting, the International Dermatology Outcome Measures (IDEOM) psoriatic disease (PsD) workgroup presented an update on their efforts toward measurement of musculoskeletal (MSK) symptoms in patients with PsD. Dr. Joseph Merola initiated the presentation emphasizing the vital importance of assessing MSK symptoms in patients with psoriasis (PsO) regardless of whether they have been diagnosed with psoriatic arthritis (PsA). He also discussed existing challenges for evaluating MSK symptoms in patients with PsO without a PsA diagnosis. Dr. Lourdes Perez-Chada then presented their work on the development and validation of the IDEOM Musculoskeletal Questionnaire (MSK-Q), a patient-reported questionnaire developed by the IDEOM to capture the intensity and impact of MSK symptoms on quality of life in patients with PsO with or without PsA. Dr. Perez-Chada also introduced a set of ongoing studies employing the IDEOM MSK-Q, highlighting the potential effects of the data collected through this innovative tool.<\/jats:p>","DOI":"10.3899\/jrheum.2024-0445","type":"journal-article","created":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T12:18:00Z","timestamp":1721045880000},"page":"51-53","source":"Crossref","is-referenced-by-count":1,"title":["GRAPPA 2023 Annual Meeting Report: Hot Topic Session on Measurement of Musculoskeletal Symptoms in Psoriatic Disease"],"prefix":"10.3899","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4569-0557","authenticated-orcid":false,"given":"Arianna J.","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7724-7309","authenticated-orcid":false,"given":"Lourdes M.","family":"Perez-Chada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4978-4072","authenticated-orcid":false,"given":"Vibeke","family":"Strand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0064-8707","authenticated-orcid":false,"given":"April W.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2927-8618","authenticated-orcid":false,"given":"Alice B.","family":"Gottlieb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6514-4353","authenticated-orcid":false,"given":"Joseph F.","family":"Merola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2262","published-online":{"date-parts":[[2024,7,15]]},"reference":[{"key":"2024120403401088000_51.Suppl_2.51.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.05.001"},{"key":"2024120403401088000_51.Suppl_2.51.2","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.clindermatol.2018.04.011","article-title":"Psoriatic arthritis and the dermatologist: an approach to screening and clinical evaluation","volume":"36","author":"Zhang","year":"2018","journal-title":"Clin Dermatol"},{"key":"2024120403401088000_51.Suppl_2.51.3","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2011.150938"},{"key":"2024120403401088000_51.Suppl_2.51.4","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1007\/s13555-023-01025-8","article-title":"Prevalence of musculoskeletal symptoms in patients with psoriasis and predictors associated with the development of psoriatic arthritis: retrospective analysis of a US claims database","volume":"13","author":"Merola","year":"2023","journal-title":"Dermatol Ther"},{"key":"2024120403401088000_51.Suppl_2.51.5","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/rheumatology\/keab310","article-title":"Using Bayesian networks to identify musculoskeletal symptoms influencing the risk of developing psoriatic arthritis in people with psoriasis","volume":"61","author":"Green","year":"2022","journal-title":"Rheumatology"},{"key":"2024120403401088000_51.Suppl_2.51.6","doi-asserted-by":"crossref","first-page":"723944","DOI":"10.3389\/fmed.2021.723944","article-title":"Early origins of psoriatic arthritis: clinical, genetic and molecular biomarkers of progression from psoriasis to psoriatic arthritis","volume":"8","author":"Pennington","year":"2021","journal-title":"Front Med"},{"key":"2024120403401088000_51.Suppl_2.51.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.11.002"},{"key":"2024120403401088000_51.Suppl_2.51.8","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1001\/jamadermatol.2018.1165","article-title":"Identifying a core domain set to assess psoriasis in clinical trials","volume":"154","author":"Callis Duffin","year":"2018","journal-title":"JAMA Dermatol"},{"key":"2024120403401088000_51.Suppl_2.51.9","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-8-38"},{"key":"2024120403401088000_51.Suppl_2.51.10","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-15-247"},{"key":"2024120403401088000_51.Suppl_2.51.11","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1177\/12034754221128796","article-title":"Utilization of the Psoriasis Epidemiology Screening Tool (PEST): a risk stratification strategy for early referral of psoriatic arthritis patients to minimize irreversible erosive joint damage","volume":"26","author":"Chang","year":"2022","journal-title":"J Cutan Med Surg"},{"key":"2024120403401088000_51.Suppl_2.51.12","first-page":"143","article-title":"The Three-Step Test-Interview (TSTI): an observation-based method for pretesting self-completion questionnaires","volume":"2","author":"Hak","year":"2008","journal-title":"Surv Res Methods"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.2024-0445","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T11:41:40Z","timestamp":1733312500000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.2024-0445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,15]]},"references-count":12,"journal-issue":{"issue":"Suppl 2","published-online":{"date-parts":[[2024,10,1]]},"published-print":{"date-parts":[[2024,10]]}},"alternative-id":["10.3899\/jrheum.2024-0445"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.2024-0445","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"type":"print","value":"0315-162X"},{"type":"electronic","value":"1499-2752"}],"subject":[],"published":{"date-parts":[[2024,7,15]]}}}